3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
27
Phase 2
8
Phase 1/2
5
Phase 1
4
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
10
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Thoracic Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Patient Acceptance of Health Care
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Lung Diseases
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Large Cell
1
Cancer Therapy-related Cardiovascular Toxicity
1
Breast Neoplasm Female
1
Interventions
pembrolizumab
3
Paclitaxel
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Paclitaxel
×
Clear all
NCT04489888
2025-06-19
MK-3475-B10
Merck Sharp & Dohme LLC
Phase 4
Completed
101 enrolled
14 charts